London
· Delayed Price · Currency is GBP · Price in GBX Faron Pharmaceuticals Oy Statistics
Total Valuation
AIM:FARN has a market cap or net worth of GBP 249.10 million. The enterprise value is 251.26 million.
| Market Cap | 249.10M |
| Enterprise Value | 251.26M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:FARN has 111.95 million shares outstanding. The number of shares has increased by 36.07% in one year.
| Current Share Class | 111.95M |
| Shares Outstanding | 111.95M |
| Shares Change (YoY) | +36.07% |
| Shares Change (QoQ) | +51.29% |
| Owned by Insiders (%) | 23.53% |
| Owned by Institutions (%) | 8.65% |
| Float | 78.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -30.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09
| Current Ratio | 1.09 |
| Quick Ratio | 0.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -102.64% |
| Return on Invested Capital (ROIC) | -7,728.89% |
| Return on Capital Employed (ROCE) | -794.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -857,402 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:FARN has paid 4,135 in taxes.
| Income Tax | 4,135 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +143.30% in the last 52 weeks. The beta is 1.18, so AIM:FARN's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +143.30% |
| 50-Day Moving Average | 220.70 |
| 200-Day Moving Average | 195.28 |
| Relative Strength Index (RSI) | 48.60 |
| Average Volume (20 Days) | 17,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.44M |
| Pretax Income | -21.43M |
| Net Income | -21.44M |
| EBITDA | -15.27M |
| EBIT | -15.44M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 7.86 million in cash and 10.02 million in debt, giving a net cash position of -2.16 million or -0.02 per share.
| Cash & Cash Equivalents | 7.86M |
| Total Debt | 10.02M |
| Net Cash | -2.16M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -8.07M |
| Book Value Per Share | -0.08 |
| Working Capital | 739,311 |
Cash Flow
| Operating Cash Flow | -19.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:FARN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.07% |
| Shareholder Yield | n/a |
| Earnings Yield | -8.61% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |